Ozempic-style drugs treat type 1 diabetes, not only type 2, study finds. News. By Jennifer Zieba published 2 July 2025 A clinical trial for semaglutide, the active ingredient in Ozempic, found ...

GLP-1 agonists, including liraglutide, are typically used to control blood sugar levels in type 2 diabetes and to promote weight loss. These drugs mimic a hormone released after eating, helping to ...

The popular diabetes and weight-loss drug semaglutide may lower the risk of dementia when taken by Type 2 diabetes patients, new research from the Case Western Reserve School of Medicine suggests.

For people who are obese and have type 2 diabetes, using Ozempic and other GLP-1 agonist drugs cuts the all-cause mortality rate by 30%, according to a new Use of GLP-1 agonists also cut the risk that ...

GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver disease and type 2 diabetes ...

Ozempic-style drugs treat type 1 diabetes, not only type 2, study finds. Jennifer Zieba. Wed, July 2, 2025 at 9:00 PM UTC. When you buy through links on our articles, Future and its syndication ...